Putin and Le Pen did not talk about National Front's financing — KremlinRussian Politics & Diplomacy March 24, 15:07
Kremlin expects ex-Duma member’s murder to be investigated thoroughlyRussian Politics & Diplomacy March 24, 15:05
Putin backs Russian Central Bank's key rate cut and regulator’s strategyBusiness & Economy March 24, 14:45
Vatican museum makes exception for Tretyakov Gallery exhibitionSociety & Culture March 24, 14:41
UK police confirm at least 50 injured in Westminster attack, two more suspects arrestedWorld March 24, 14:31
National Guard units in North Caucasus on high alert after gunmen’s attackMilitary & Defense March 24, 14:25
Putin meets France's Le Pen in KremlinRussian Politics & Diplomacy March 24, 14:18
Ukraine’s Security Service confirms Russian MP’s assassin had military backgroundWorld March 24, 14:17
Russian Aerospace Force to receive 200 medium-range aircraft missiles in 2017Military & Defense March 24, 14:14
MOSCOW, December 22. /TASS/. Some 16 major Russian pharmaceutical companies have stopped the production of “the cheapest and the most essential drugs,” including antibiotics and fluids, the chairman of the State Duma health committee Sergey Kalashnikov said on Monday.
“This comes due to a sharp increase in the dollar price for the substances which are bought abroad,” Kalashnikov said, adding that the prime cost of medicines is now some three or four times higher than the actual price amid weakened ruble.
The members of the State Duma health committee as well as representatives of the Russian Health Ministry, the Ministry of Industry and Trade, the Federal Anti-Monopoly Service and the Federal Tariff Service are due to focus on the situation at an urgent meeting later on Monday.
“The main goal is to develop a concept for work in emergency conditions to ensure uninterrupted access to medicines,” Kalashnikov said, explaining that the idea is to adjust prices for foreign-made life-saving drugs and resume the production of pharmaceutical substances in Russia.
The lawmaker in particular proposes that Russia should follow the example of India and Brazil and introduce a mechanism of mandatory licensing when “it is allowed to manufacture medicines, generics if a patent has not expired.” This concerns the “most expensive medicines” which are used to treat such diseases as cancer and AIDS, he said.